Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

COVID-19 2Urinary Bladder Neoplasms 1Testicular Neoplasms 1

Interventions

Standard of Care 8Surveys and Questionnaires 7COVID-19 Vaccines 6Blood Specimen Collection 6BNT162 Vaccine 6Specimen Handling 52019-nCoV Vaccine mRNA-1273 5Hydroxychloroquine 4Surgical Procedures, Operative 3Practice Guidelines as Topic 3tocilizumab 2sotrovimab 2sinovac COVID-19 vaccine 2cilgavimab and tixagevimab drug combination 2Sodium Chloride 2Pandemic Preparedness 2Data Collection 2CVnCoV COVID-19 vaccine 2COH04S1 COVID-19 vaccine 2Azithromycin 2selinexor 1remdesivir 1regorafenib 1proxalutamide 1palbociclib 1ogalvibart 1monalizumab 1lenzilumab 1heterologous prime boost COVID-19 vaccination 1crexavibart 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
COVID-19 × Pandemic Preparedness × Clear all
NCT05083143 2022-04-27

The Impact of the COVID-19 Pandemic on Testicular Cancer

Ankara Training and Research Hospital

Completed
50 enrolled
Genitourinary

COVID-19, Testicular Neoplasms

NCT04900259 2021-10-06

The Effect of the COVID-19 Pandemic on Primary Bladder Cancer Presentations

Ankara Training and Research Hospital

Completed
183 enrolled
Genitourinary

COVID-19, Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡